Pathos is a clinical-stage biotechnology company dedicated to transforming drug development with AI technologies. It leverages oncology and genomic data to uncover novel biological insights and optimize patient selection, ensuring that innovative therapies reach patients. Partnering with biopharmaceutical companies helps revive shelved drug programs and accelerates biomarker-driven development paths.
📋 Overview of Pathos
📙 About Pathos
💰 Recent Investors of Pathos
Builders VC, Eric Lefkofsky, Investor
© 2025 Bot Memo. All Rights Reserved.
